Journal of clinical oncology (JCO) |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2. |
Jan. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study |
juil. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer |
nov. 15 |
4 ♥ |
Endoscopie/Imagerie, Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial |
Jan. 18 |
3 ♥ |
Cancers autres |
Journal of clinical oncology (JCO) |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110). |
Jan. 19 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial |
aoû. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database. |
fév. 18 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. |
oct. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Associations of Pre- and Postdiagnosis Diet Quality With Risk of Mortality Among Men and Women With Colorectal Cancer |
oct. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
National Trends in Nonoperative Management of Rectal Adenocarcinoma. |
juin. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. |
sep. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. |
juin. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. |
oct. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
mar. 18 |
4 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Popstantot |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. |
mar. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial. |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
New England Journal of Medicine (NEJM) |
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component |
sep. 15 |
4 ♥ |
Foie |
New England Journal of Medicine (NEJM) |
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
New England Journal of Medicine (NEJM) |
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. |
aoû. 16 |
3 ♥ |
Foie |